1219094

Otsuka Pharmaceutical Development & Commercialization, Inc — FEI 3000718406

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 7, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Rockville, MD (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)